These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Common pathways of depression and pain. Delgado PL J Clin Psychiatry; 2004; 65 Suppl 12():16-9. PubMed ID: 15315473 [TBL] [Abstract][Full Text] [Related]
23. Venlafaxine-tramadol similarities. Markowitz JS; Patrick KS Med Hypotheses; 1998 Aug; 51(2):167-8. PubMed ID: 9881825 [TBL] [Abstract][Full Text] [Related]
24. Venlafaxine and ecchymosis. Kohn S; Labbate LA Can J Psychiatry; 1997 Feb; 42(1):91. PubMed ID: 9040933 [No Abstract] [Full Text] [Related]
25. Venlafaxine: loss of antidepressant effect and its management. Sharma V J Clin Psychiatry; 1998 Jul; 59(7):381-2. PubMed ID: 9714268 [No Abstract] [Full Text] [Related]
26. Adjunctive lamotrigine treatment for major depression. Maltese TM Am J Psychiatry; 1999 Nov; 156(11):1833. PubMed ID: 10553753 [No Abstract] [Full Text] [Related]
27. Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine. Tamura RN; Lu Y J Psychiatr Res; 2003; 37(2):175-6; author reply 176-7. PubMed ID: 12842172 [No Abstract] [Full Text] [Related]
28. Venlafaxine: a new dimension in antidepressant pharmacotherapy. J Clin Psychiatry; 1993 Mar; 54(3):119-26. PubMed ID: 8468312 [No Abstract] [Full Text] [Related]
30. New approaches to the treatment of depression. Leonard BE J Clin Psychiatry; 1996; 57 Suppl 4():26-33. PubMed ID: 8636063 [TBL] [Abstract][Full Text] [Related]
31. STAR*D level IV methodology. Wingo AP; Ghaemi SN Am J Psychiatry; 2007 Apr; 164(4):681; author reply 681. PubMed ID: 17403987 [No Abstract] [Full Text] [Related]
32. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177 [TBL] [Abstract][Full Text] [Related]
33. The psychopharmacology of painful physical symptoms in depression. Stahl SM J Clin Psychiatry; 2002 May; 63(5):382-3. PubMed ID: 12019660 [No Abstract] [Full Text] [Related]
34. A case report of paranoid delusion with venlafaxine use. Iraqi AH J Am Geriatr Soc; 2003 Jul; 51(7):1045-6. PubMed ID: 12834535 [No Abstract] [Full Text] [Related]
35. Treatment of major depression: is improvement enough? Ferrier IN J Clin Psychiatry; 1999; 60 Suppl 6():10-4. PubMed ID: 10235119 [TBL] [Abstract][Full Text] [Related]
36. Glad about SAD (PD). Friedman JH; Weintraub D Neurology; 2012 Apr; 78(16):1198-9. PubMed ID: 22496197 [No Abstract] [Full Text] [Related]
37. Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia. Machado M; Lopera MM; Diaz-Rojas J; Jaramillo LE; Einarson TR; Rev Panam Salud Publica; 2008 Oct; 24(4):233-9. PubMed ID: 19133171 [TBL] [Abstract][Full Text] [Related]
38. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. Frodl T; Scheuerecker J; Schoepf V; Linn J; Koutsouleris N; Bokde AL; Hampel H; Möller HJ; Brückmann H; Wiesmann M; Meisenzahl E J Clin Psychiatry; 2011 Apr; 72(4):448-57. PubMed ID: 20868630 [TBL] [Abstract][Full Text] [Related]
39. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Little JT; Ketter TA; Kimbrell TA; Dunn RT; Benson BE; Willis MW; Luckenbaugh DA; Post RM Biol Psychiatry; 2005 Feb; 57(3):220-8. PubMed ID: 15691522 [TBL] [Abstract][Full Text] [Related]